NYSE:IQVLife Sciences
IQVIA Collaboration With Sarah Cannon Puts Clinical Trial Role In Focus
IQVIA Holdings (NYSE:IQV) has entered into a collaboration with Sarah Cannon Research Institute focused on clinical trial processes.
The partnership is aimed at improving how trials are designed, run, and managed across participating research sites.
The two organizations plan to combine data, technology, and oncology research expertise to support more efficient studies.
IQVIA Holdings, through its data, technology, and contract research operations, sits at the intersection of healthcare and...